Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib Maintenance in Metastatic Pancreatic Cancer
NCT00967603Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Feb 2008
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in pancreatic adenocarcinoma (PDAC), sponsored by IRCCS Ospedale San Raffaele. Started Feb 2008; status: completed.
02
Drugs
sunitinib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00967603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00967603.